A
aTyr Pharma, Inc. (ATYR)
NCM – Real Time Price. Currency in USD
0.53
-0.03 (-5.75%)
At close: Jun 26, 2026, 4:00 PM EDT
0.56
+0.03 (5.36%)
After-hours: Jun 26, 2026, 7:23 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.53
-0.03 (-5.75%)
At close: Jun 26, 2026, 4:00 PM EDT
0.56
+0.03 (5.36%)
After-hours: Jun 26, 2026, 7:23 PM EDT
No Data
There are no news for this stock.
Total debt $11.7M significantly exceeds cash reserves ($10.0M), raising financial stability concerns
Total current assets $67.6M exceed Total current liabilities $11.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$12.7M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 5.78 | 6.05 | 10 | |
| Quick ratio | 5.78 | 5.63 | 10 | |
| Debt to Equity | 0.20 | 0.30 | 9.0 | |
| Debt to Assets | 0.15 | 1.04 | 8.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 10M | 353K | 235K | 190K | 190K |
| Gross Profit | 9M | -2M | -1M | -1M | -1M |
| Operating Income | -46M | -55M | -68M | -78M | -73M |
| Net Income | -45M | -50M | -64M | -74M | -70M |
| EBITDA | -45M | -52M | -66M | -76M | -72M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 43.51 | 5.5 |
| Next quarter | -100 | 46.15 | 5.5 |
| Current year | -100 | 28.44 | 5.5 |
| Next year | N/A | -12.66 | 1.0 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 22.72 | 21.43 | -3.49 | 7.8 |
| Y/Y | 999 | 27.48 | 35.29 | 17.93 | 9.8 |
| 3y average | -49.71 | -17.97 | 18.91 | -20.16 | 3.0 |
| 5y average | 149.97 | -39.25 | 13.27 | -41.17 | 5.0 |
| Weighted average score | 6.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |